Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Carbamazepine Treatment of Cocaine Dependence - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00000242
Recruitment Status : Completed
First Posted : September 21, 1999
Last Update Posted : April 7, 2017
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Medical University of South Carolina

Tracking Information
First Submitted Date  ICMJE September 20, 1999
First Posted Date  ICMJE September 21, 1999
Last Update Posted Date April 7, 2017
Actual Study Start Date  ICMJE October 1, 1992
Actual Primary Completion Date January 25, 1997   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: June 23, 2005)
  • Severity addiction
  • Amount of drug use
  • Affective stability
  • Medication compliance
Original Primary Outcome Measures  ICMJE Same as current
Change History Complete list of historical versions of study NCT00000242 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Carbamazepine Treatment of Cocaine Dependence - 1
Official Title  ICMJE Carbamazepine Treatment of Cocaine Dependence
Brief Summary The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Phase 2
Study Design  ICMJE Primary Purpose: Treatment
Condition  ICMJE
  • Cocaine-Related Disorders
  • Substance-Related Disorders
Intervention  ICMJE Drug: Carbamazepine
Study Arms  ICMJE Not Provided
Publications * (1) Brady KT et. al. Features of cocaine dependence with concurrent alcohol abuse. Drug and Alcohol Depend. 1995, 39(1):69-71. (2) Brady KT et. al. Personality disorder and assault history in substance-dependent individuals. Am J on Addictions. 1995, 4(4):306-312. (3) Dansky et. al. Use of self-report measures of crime-related posttraumatic stress disorder with substance use disordered patients. Journal of Substance Abuse Treatment. (in press). (4) Sonne an Presentation at CPDD meeting, 1996.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Enrollment  ICMJE
 (submitted: June 23, 2005)
0
Original Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE January 25, 1997
Actual Primary Completion Date January 25, 1997   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE Please contact site for information.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 65 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00000242
Other Study ID Numbers  ICMJE NIDA-07761-1
R29DA007761 ( U.S. NIH Grant/Contract )
R29-07761-1
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Medical University of South Carolina
Study Sponsor  ICMJE Medical University of South Carolina
Collaborators  ICMJE National Institute on Drug Abuse (NIDA)
Investigators  ICMJE
Principal Investigator: Kathleen Brady, Ph.D. Medical University of South Carolina
PRS Account Medical University of South Carolina
Verification Date July 1996

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP